Emerging therapies for NASH - the future is now

Expert Rev Clin Pharmacol. 2017 May;10(5):467-469. doi: 10.1080/17512433.2017.1305269.
No abstract available

Keywords: NAFLD; NASH; drug development; elafibranor; obeticholic acid; therapy.

Publication types

  • Editorial

MeSH terms

  • Drug Design*
  • Humans
  • Non-alcoholic Fatty Liver Disease / drug therapy*
  • Non-alcoholic Fatty Liver Disease / epidemiology
  • Non-alcoholic Fatty Liver Disease / physiopathology